Dietary supplements for the management of COVID-19 symptoms
The aim of this paper is to review the relationship between COVID-19 and nutrition and to discuss to most up-to-date
A forum for researchers, students and applicants in the field of cyclodextrin technology
The aim of this paper is to review the relationship between COVID-19 and nutrition and to discuss to most up-to-date
Remdesivir has emerged as a promising antiviral drug against SARS-CoV-2. However, data regarding the clinical benefits of remdesivir in patients
In terms of solubilization effect, it was found that phase solubility of RDV increased significantly from intrinsic 1.7 mmol/L at
There were 648 patients enrolled in the study (216 cases and 432 controls). Viral clearance (VC) was observed in 490
Prof. bernard Martel (University of Lille, France) showed how the new cyclodextrin-based mask was developed from the in-lab optimization to
As remdesivir, the first FDA-approved drug for SARS-CoV-2 infection, can be used only for hospitalized patients due to intravenous administration,
The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal
The press release was published on the U.S. Food and Drug Administration website: On Apr. 26, 2022, the U.S. Food
The aim of this report is to review the literature and shed light on the uncertainties surrounding the use of
The Hungarian Association of Innovation awarded CycloLab with this prestigious prize due to its meaningful and very profitable innovation concerning